Form 4: Schrodinger Director Rosana Kapeller-Libermann Receives Stock Options and Restricted Stock Units

Director Rosana Kapeller-Libermann acquired stock options and restricted stock units in Schrodinger, Inc. on June 18, 2024.

Summary

• Rosana Kapeller-Libermann, a director of Schrodinger, Inc., reported changes in beneficial ownership on June 20, 2024.
• On June 18, 2024, she was granted 5,000 restricted stock units (RSUs) and an option to buy 8,550 shares of common stock at an exercise price of $19.32.
• The RSUs and options vest on the twelve-month anniversary of the grant date or the date of the next annual meeting of stockholders, subject to continued service.
• Following these transactions, Kapeller-Libermann beneficially owns 11,250 shares of common stock, including 5,000 unvested RSUs, and options to purchase 8,550 shares.

Sentiment

Score: 7

Explanation: The document reflects a standard equity grant, which is generally viewed positively as it aligns management interests with shareholders. There are no indications of negative news or concerns.

Positives

• The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the RSUs and stock options suggests an expectation of continued service from the director.

Industry Context

Grants of stock options and restricted stock units are common practices in the biotech and pharmaceutical industries to incentivize and retain key personnel, aligning their interests with the long-term success of the company.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotechnology industry.
• Companies like Moderna and BioNTech also use stock options and RSUs to incentivize their executives.
• The vesting schedule of twelve months is fairly standard, aligning with typical industry practices for equity compensation.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align the director's interests with the company's performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates